Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Bio-Rad Laboratories, Inc. (BIO) Profit Margins

Over the twelve months to 2026-06-30, Bio-Rad Laboratories, Inc. (BIO) had gross margin 51.9%, operating margin 2.1%, net margin 8.6%, free cash flow margin 13.6%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BIOBio-Rad Laboratories, Inc.Follow BIO — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
9.9B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2010
Dec 10		FY2011
Dec 11		FY2012
Dec 12		FY2013
Dec 13		FY2014
Dec 14		FY2015
Dec 15		FY2016
Dec 16		FY2017
Dec 17		FY2018
Dec 18		FY2019
Dec 19		FY2020
Dec 20		FY2021
Dec 21		FY2022
Dec 22		FY2023
Dec 23		FY2024
Dec 24		FY2025
Dec 25		TTM
Jun 26		Trend
Gross margin56.6%56.9%55.8%55.3%54.2%55.5%55.0%55.0%53.4%54.4%56.5%56.1%55.9%53.4%53.7%51.9%51.9%
Operating margin14.7%14.7%12.8%7.9%6.9%8.3%2.7%5.5%-4.5%9.9%16.6%17.1%17.2%12.6%10.5%1.8%2.1%
Net margin9.6%8.6%8.0%3.6%4.1%5.4%1.3%5.7%16.0%76.1%149.8%145.6%-129.5%-23.9%-71.9%29.4%8.6%
FCF margin7.2%7.7%6.0%2.9%7.0%3.7%3.6%-0.3%6.8%15.5%18.7%18.3%2.9%8.2%11.3%14.5%13.6%

USD billions · SEC XBRL

Bio-Rad Laboratories, Inc. — questions

What is Bio-Rad Laboratories, Inc.'s gross margin?
51.9% over the twelve months to 2026-06-30.
What is Bio-Rad Laboratories, Inc.'s operating margin?
2.1% over the twelve months to 2026-06-30.
What is Bio-Rad Laboratories, Inc.'s net profit margin?
8.6% over the twelve months to 2026-06-30.

Every figure on this page comes from Bio-Rad Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.